Attached files

file filename
10-K - 10-K - AGIOS PHARMACEUTICALS, INC.agio-123117x10k.htm
EX-32.2 - EXHIBIT 32.2 - AGIOS PHARMACEUTICALS, INC.agio-ex322x123117.htm
EX-32.1 - EXHIBIT 32.1 - AGIOS PHARMACEUTICALS, INC.agio-ex321x123117.htm
EX-31.2 - EXHIBIT 31.2 - AGIOS PHARMACEUTICALS, INC.agio-ex312x123117.htm
EX-31.1 - EXHIBIT 31.1 - AGIOS PHARMACEUTICALS, INC.agio-ex311x123117.htm
EX-23.1 - EXHIBIT 23.1 - AGIOS PHARMACEUTICALS, INC.agio-ex231x123117.htm
EX-21.1 - EXHIBIT 21.1 - AGIOS PHARMACEUTICALS, INC.agio-ex211x123117.htm


Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
1.
Registration Statement (Form S-8, File No. 333-190101) pertaining to the 2007 Stock Incentive Plan of Agios Pharmaceuticals, Inc., 2013 Stock Incentive Plan of Agios Pharmaceuticals, Inc., and 2013 Employee Stock Purchase Plan of Agios Pharmaceuticals, Inc.;
2.
Registration Statement (Form S-8, File No. 333-193802) pertaining to the 2013 Stock Incentive Plan of Agios Pharmaceuticals, Inc.;
3.
Registration Statement (Form S-8, File No. 333-201796) pertaining to the 2013 Stock Incentive Plan of Agios Pharmaceuticals, Inc.;
4.
Registration Statement (Form S-8, File No. 333-209755) pertaining to the 2013 Stock Incentive Plan of Agios Pharmaceuticals, Inc.;
5.
Registration Statement (Form S-8, File No. 333-216106) pertaining to the 2013 Stock Incentive Plan of Agios Pharmaceuticals, Inc.; and
6.
Registration Statement (Form S-3, File No. 333-221960) and related Prospectus of Agios Pharmaceuticals, Inc. for the registration of debt securities, common stock, preferred stock, and warrants;
of our report dated February 16, 2017, with respect to the consolidated financial statements of Agios Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2017.

/s/ Ernst & Young LLP

Boston, Massachusetts
February 14, 2018